HKB's Mouse Asthma Models provide pharmaceutical researchers with robust platforms for developing asthma therapeutics. Our portfolio includes OVA-induced allergic asthma, HDM-challenged models, and IL-33-driven severe asthma models representing various asthma phenotypes. These models replicate key features of asthma including airway hyperresponsiveness, eosinophilic inflammation, mucus hypersecretion, and airway remodeling.